The Estée Lauder Companies Inc. (EL) slips after deep earnings beat
The Estée Lauder Companies Inc. (EL) beat EPS and revenue estimates, lifted guidance, and posted broad-based organic growth, yet the stock still slipped. This deep dive weighs margin expansion, fragrance-led momentum, China recovery, and cash flow improvement against the market’s demand for sustained execution.
The Estée Lauder Companies Inc. (EL) delivered a strong fiscal 2027 first-quarter beat, with EPS of $0.72 and revenue of $3.72 billion both topping estimates, while management raised full-year organic sales and margin guidance. Even so, the stock fell 2.8% as investors remain cautious and want to see sustained execution before fully rewarding the turnaround.
The Estée Lauder Companies Inc. (EL) slips 2.80% to $106.17 in regular trading, even after fiscal 2027 first-quarter EPS of $0.72 beat the $0.508 estimate and revenue of $3.72B topped the $3.65B consensus. EL's 6% organic sales growth and raised fiscal 2027 outlook strengthen the recovery story, but the stock action shows that investors still demand proof of durable execution.
Key Takeaways
EPS reached $0.72 versus the $0.508 estimate, while revenue came in at $3.72B against the $3.65B consensus.
Fragrance led the portfolio with 20% organic sales growth. Skin care rose 4%, makeup returned to organic growth for a second straight quarter, and hair care stabilized.
CEO Stephane de la Faverie raised fiscal 2027 organic sales guidance to 4% to 5.5% from 3% to 5% and lifted operating margin expansion guidance to 170 to 250 basis points.
Reported sales increased 7%, every geographic region grew, and Mainland China delivered 9% organic sales growth.
Gross margin expanded 240 basis points to 75.7%, while operating margin rose 480 basis points to 12.1%.
CFO Akhil Shrivastava highlighted stronger cash productivity, with operating cash use improving to $166M from $340M and free cash flow use improving to $235M from $436M.
The analyst consensus remains Buy, with 1 Strong Buy, 21 Buy, 20 Hold, and 4 Sell ratings. Barclays upgraded EL before the print, while Piper Sandler, JPMorgan, Jefferies, Canaccord Genuity, and Wells Fargo raised targets or retained constructive coverage.
Financial Performance: Revenue, Margins, and EPS
The EL earnings result delivered a clean headline beat. Revenue of $3.72B exceeded the $3.65B estimate, while EPS of $0.72 surpassed the $0.508 forecast. The company reported 6% organic sales growth and 7% reported sales growth. Both measures improved the quality of the recovery because growth extended across categories and regions.
Fragrance was the standout category. Organic sales rose 20%, supported by Le Labo, TOM FORD, Jo Malone London, and KILIAN PARIS. Management also cited strong demand for new launches, including TOM FORD Ombré Leather Reserve and KILIAN PARIS's Cocktails Collection. In Western Europe, fragrance retail sales grew more than four times faster than the industry, while the United States also delivered industry outperformance.
Skin care grew 4% organically, with La Mer, Estée Lauder, and The Ordinary contributing across luxury, prestige, and entry price tiers. Makeup posted a second consecutive quarter of organic growth. M·A·C and TOM FORD both grew at double-digit rates, supported by launches in lip, face, and eye products. Hair care improved sequentially from a modest decline, although Aveda faced brand-specific supply chain and logistics issues.
The latest full-year segment figures show skin care remains the largest business. Fiscal 2026 revenue totaled $7.338B for skin care, $4.276B for makeup, $2.779B for fragrance, and $565M for hair care. Compared with fiscal 2025, fragrance revenue rose from $2.491B to $2.779B, while skin care increased from $6.962B to $7.338B.
Profitability provided an additional layer to the beat. Gross margin reached 75.7%, up from 73.3% a year earlier. Operating margin reached 12.1%, compared with 7.3% in the prior-year period. Strategic pricing, procurement savings, manufacturing efficiency, and operating leverage supported the expansion. At the same time, consumer-facing investment increased 8%, while nonconsumer-facing expenses fell 1%.
EPS increased 125% from $0.32 a year earlier. The recent earnings path remains uneven, with EPS of $0.39 on Aug. 19, $0.91 on May 1, $0.89 on Feb. 5, and a loss of $0.32 on June 30. The current $0.72 result therefore marks a strong improvement from the year-ago quarter and the June loss, while remaining below the two stronger spring and winter prints.
The effective tax rate also improved to 31.9% from 40.5%. Capital spending declined to $69M from $96M. These figures helped support better cash performance, even as the first quarter typically uses cash and the company continued to fund restructuring and working capital.
Market Reaction and Analyst Response
EL traded at $106.17 during the Nov. 2 regular session, down 2.80%. Volume reached 5,050,645 shares versus an average of 3,287,693. The decline came despite the EPS and revenue beats, creating a useful reminder that a strong quarter and a strong short-term stock reaction are separate matters.
The analyst distribution remains constructive but divided. Twenty-one analysts rate EL Buy and 20 rate it Hold, with 1 Strong Buy and 4 Sell ratings. That mix supports a Buy consensus, while the large Hold group shows that confidence in the turnaround has not become universal.
The dated actions around the EL earnings report leaned toward higher targets. Piper Sandler raised its target to $125 from $115 on Oct. 23 and kept an Overweight rating, citing the innovation pipeline. Canaccord Genuity lifted its target to $109 from $90 on Oct. 22 while maintaining Hold.
JPMorgan raised its target to $115 from $112 on Oct. 19, kept Overweight, and added a Catalyst Watch ahead of the report. Jefferies increased its target to $120 from $100 while retaining Hold. Barclays made the clearest rating move, upgrading EL to Overweight from Equal Weight and raising its target to $108 from $97 on Oct. 5. Wells Fargo kept Equal Weight but raised its target to $104 from $95.
The pattern matters. Analysts have raised targets as organic growth broadened across regions and categories, yet several firms retained Hold ratings. That combination reflects improved earnings momentum alongside continued debate over valuation and the durability of the recovery.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
CEO Stephane de la Faverie framed the quarter as evidence that Estée Lauder's Beauty Reimagined plan is moving beyond repair work and into growth. His message focused on broader brand reach, stronger innovation, and a more balanced geographic mix.
"We have moved beyond restoring growth. Through Beauty Reimagined, we are creating a stronger foundation for sustained, profitable growth." - Stephane de la Faverie, CEO, EL earnings call
De la Faverie raised fiscal 2027 organic sales guidance to 4% to 5.5%, up from 3% to 5%. With foreign exchange translation, reported sales growth is forecast at 5% to 6.5%. He also raised expected operating margin expansion to 170 to 250 basis points from 150 to 230 basis points, on top of the 320-basis-point improvement achieved in fiscal 2026.
"This quarter, we delivered another data point to prove our momentum is real and durable." - Stephane de la Faverie, CEO, EL earnings call
CFO Akhil Shrivastava focused on the financial machinery behind the turnaround. He tied the margin gains to pricing, procurement, manufacturing efficiency, cost discipline, and the ongoing Profit Recovery and Growth Plan.
"We remain focused on delivering sustainable growth, expanding margins and strengthening cash generation." - Akhil Shrivastava, CFO, EL earnings call
Shrivastava also highlighted the cash impact of the plan. Operating cash use improved by roughly half from the prior year, while free cash flow use improved by $201M. The company expects most of the Profit Recovery and Growth Plan's full-run-rate benefits by the end of fiscal 2027.
"Our strong cash productivity and disciplined capital spending drove a notable improvement in free cash flow in the quarter." - Akhil Shrivastava, CFO, EL earnings call
Bottom Line
EL delivered the combination investors want from a turnaround: an EPS beat, revenue above consensus, broad organic growth, stronger margins, and higher full-year guidance. The 2.80% decline despite those results shows that the stock still carries a high proof standard, but the 4% to 5.5% organic sales outlook and fragrance-led momentum give the recovery a stronger foundation.
+Why did Estée Lauder stock fall after beating earnings?
The Estée Lauder Companies Inc. (EL) beat fiscal 2027 first-quarter EPS and revenue estimates, but shares still fell 2.80% to $106.17. Investors appear to want more proof that the recovery is durable, despite the stronger quarter and raised guidance.
+What were Estée Lauder's Q1 fiscal 2027 earnings and revenue results?
Estée Lauder reported adjusted EPS of $0.72 versus the $0.508 estimate. Revenue came in at $3.72 billion, above the $3.65 billion consensus.
+Did Estée Lauder raise its fiscal 2027 outlook?
Yes. Management raised fiscal 2027 organic sales growth guidance to 4% to 5.5% from 3% to 5% and increased operating margin expansion guidance to 170 to 250 basis points. That signals management has more confidence in the recovery trajectory.
+Which Estée Lauder business segments performed best in the quarter?
Fragrance was the standout, with 20% organic sales growth led by Le Labo, TOM FORD, Jo Malone London, and KILIAN PARIS. Skin care rose 4% organically, makeup returned to organic growth for a second straight quarter, and hair care stabilized.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
▌The Full Report
Want the full picture on EL?
The analyst-grade research report — charts, grades, valuation, and price targets — in 10 minutes.
